You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclosporine Toxicity

Showing 1 - 25 of 6,575
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stem Cell Transplantation Trial in Houston (Fludarabine, Dexamethasone, Cyclophosphamide)

Not yet recruiting
  • Stem Cell Transplantation
  • Houston, Texas
    M D Anderson Cancer Center
May 4, 2022

Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses Trial in Nashville (Harmonized supportive care, Cyclosporine 5 mg/kg bid

Not yet recruiting
  • Stevens-Johnson Syndrome
  • Toxic Epidermal Necrolyses
  • Harmonized supportive care
  • +2 more
  • Nashville, Tennessee
    Vanderblt University Medical Center
Dec 29, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Brentuximab Vedotin, Cyclosporine, Pharmacokinetic

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Aplastic Anemia Trial in Tianjin (Avatrombopag 20 MG Oral Tablet)

Recruiting
  • Aplastic Anemia
  • Avatrombopag 20 MG Oral Tablet
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 4, 2022

Severe Aplastic Anemia Trial in Tianjin (Avatrombopag)

Recruiting
  • Severe Aplastic Anemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jun 22, 2022

Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

Recruiting
  • Aplastic Anemia
  • +3 more
  • Anti-Thymocyte Globulin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Microsampling Assays for Immunosuppressive Drugs in Children

Withdrawn
  • Immunosuppression
  • Microsampling
  • Philadelphia, Pennsylvania
    Children's Hospital of Phildelphia
Mar 17, 2022

Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)

Active, not recruiting
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
  • rituximab
  • +7 more
  • Sacramento, California
    University of California Davis
Nov 28, 2022

Eltrombopag Trial in Assiut (Eltrombopag)

Completed
  • Eltrombopag
  • Assiut, Egypt
    Facility of medicine
Jan 13, 2022

Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)

Not yet recruiting
  • Immune Tolerance
  • +2 more
  • Tacrolimus or Cyclosporine A
  • Tianjin, Tianjin, China
    Tianjin First Central Hospital
Nov 23, 2023

Cyclosporine Short Infusion Versus Continuous Infusion Post

Recruiting
  • Allogenic Bone Marrow Transplantation
  • Cyclosporin with a daily dose of 3 mg/kg/day intravenously over 2 h (short infusion) every 12 h
  • Cairo, Egypt
    Shaymaa Mohammed Mohammed Youssef El-Awady
Apr 10, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,

Completed
  • Acute Biphenotypic Leukemia
  • +6 more
  • Aurora, Colorado
  • +2 more
Jan 12, 2022

Leukemia, Lymphoma, GVHD Trial in Australia, United States (cyclosporine, cyclosporine and methotrexate)

Terminated
  • Leukemia
  • +2 more
  • Los Angeles, California
  • +12 more
May 3, 2021

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Tel Aviv (cyclosporine in combination with carfilzomib and

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • cyclosporine in combination with carfilzomib and dexamethasone
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Apr 19, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Severe Aplastic Anemia Trial in Worldwide (eltrombopag, Cyclosporine)

Completed
  • Severe Aplastic Anemia
  • Ribeirao Preto, SP, Brazil
  • +19 more
Jun 29, 2022

Calcineurin Inhibitors Levels in Egyptian Renal Transplant

Completed
  • Renal Transplantation
    • Cairo, Egypt
      Ain shams university specialized hospital
    Mar 25, 2021

    Graft Vs Host Disease, Hematopoietic Tumor Trial in Brazil (Methotrexate Injectable Solution)

    Recruiting
    • Graft Vs Host Disease
    • Hematopoietic Neoplasm
    • Methotrexate Injectable Solution
    • Rio De Janeiro, RJ, Brazil
    • +3 more
    Sep 10, 2021

    Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

    Not yet recruiting
    • Aplastic Anemia
    • Drug Effect
    • Herombopag + CsA
    • rhTPO combined with Herombopag + CsA
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Aplastic Anemia Trial in Assiut (Combination of thrombopoietin mimetic and cyclosporin A)

    Completed
    • Aplastic Anemia
    • Combination of thrombopoietin mimetic and cyclosporin A
    • Assiut, Egypt
      Assiut university hospital Internal Medicine Department Hematolo
    Sep 28, 2021

    Juvenile Dermatomyositis Trial in Genoa (3 MPDN pulse + PDN, 3 MPDN pulse + PDN + CSA, 3 MPDN pulse + PDN + MTX)

    Completed
    Has Results
    • Juvenile Dermatomyositis
    • 3 MPDN pulse + PDN
    • +2 more
    • Genoa, Italy
      Istituto Giannina Gaslini
    Feb 22, 2021

    Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)

    Recruiting
    • Dry Eye Syndromes
    • SCAI-001 0.01% eyedrop
    • +2 more
    • Bucheon, Korea, Republic of
    • +10 more
    Feb 21, 2023

    Severe Aplastic Anemia Trial run by the NHLBI (Cohort 1: hATG, CsA, EPAG Day 14 to Month 6, Cohort 2: hATG, CsA, EPAG Day 14 to

    Recruiting
    Has Results
    • Severe Aplastic Anemia
    • Cohort 1: hATG, CsA, EPAG Day 14 to Month 6
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 5, 2022

    Fanconi Anemia Trial in Minneapolis (biological, drug, procedure)

    Completed
    Has Results
    • Fanconi Anemia
    • Anti-Thymocyte Globulin
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Oct 8, 2021